I believe you mean tech and refer to ADAPT, and I totally agree with you except for the past tense as we have it not had it.
I don’t understand your point considering WP has taken this tech from the relatively small patch space and repositioned AVR in the multi-billion dollar TAVR space.
If this all comes to fruition as it appears on track to do then WP will have been worth every cent of what he has been paid including cashing in on his options.
Bioshares adds Anteris to their model portfolio., page-45
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.60 |
Change
-0.100(0.53%) |
Mkt cap ! $357.5M | |||
| Open | High | Low | Value | Volume |
| $18.70 | $18.77 | $18.21 | $664.1K | 35.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $18.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.69 | 53 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |